The critical role of tissue angiotensin-converting enzyme as revealed by genetargeting in mice

Journal of Clinical Investigation

Volumn 99, Issue 10, 1997, Pages 2375-2385

  Esther Jr , Charles R ^a   Marino, Elaine M ^a   Howard, Tom E ^d   Machaud, Annie ^b   Corvol, Pierre ^b   Capecchi, Mario R ^c   Bernstein, Kenneth E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b l'alimentation et l'Environnement   (France)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

blood pressure; kidney; male fertility; peptidyl dipeptidase A; urine concentration

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE TARGETING; KIDNEY CONCENTRATING CAPACITY; MALE; MALE FERTILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 1842292171     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119419     Document Type: Article

References (30)

1. Corvol, P., T.A. Willaims, and F. Soubrier. 1995. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol. 248:283-305.
2. Bernstein, K.E., and B.C. Berk. 1993. The biology of angiotensin II receptors. Am. J. Kidney Dis. 2:745-754.
3. Soubrier, F., F. Alhenc-Gelas, C. Hubert, J. Allegrini, M. John, G. Tregear, and P. Corvol. 1988. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. USA. 85:9386-9390.
4. Bernstein, K.E., B.M. Martin, A.S. Edwards, and E.A. Bernstein. 1989. Mouse angiotensin I-converting enzyme is a protein composed of two homologous domains. J. Biol. Chem. 264:11945-11951.
5. Wei, L., F. Alhenc-Gelas, P. Corvol, and E. Clauser. 1991. The two homologous domains of the human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266:9002-9008.
6. Jaspard, E., L. Wei, and F. Alhenc-Gelas. 1993. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J. Biol. Chem. 268:9496-9503.
7. Ehlers, M.R.W., and J.F. Riordan. 1991. Angiotensin converting enzyme: zinc-and inhibitor-binding stiochiometries of the somatic and testis isozymes. Biochemistry. 30:7118-7126.
8. Rieger, K.J., N. Saez-Servent, M.P. Papet, J. Wdzieczak-Bakala, J.L. Morgat, J. Thierry, W. Voelter, and M. Lenfant. 1993. Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. Biochem. J. 296:373-378.
9. Azizi, M., A. Rousseau, E. Ezan, T.T. Guyene, S. Michelet, J.M. Grognet, M. Lenfant, P. Corvol, and J. Menard. 1996. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J. Clin. Invest. 97:839-844.
10. Beldent, V., A. Michaud, L. Wei, M.T. Chauvet, and P. Corvol. 1993. Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site. J. Biol. Chem. 268:26428-26434.
11. Ng, K.K., and J.R. Vane. 1967. Conversion of angiotensin I to angiotensin II. Nature (Lond.). 216:762-766.
12. Waeber, B., J. Nussberger, L. Juillerat, and H.R. Brunner. 1989. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity. J. Cardiovasc. Pharmacol. 14(Suppl. 4):S53-S59.
13. Berecek, K.H., S.J. King, and J.N. Wu. 1993. Angiotensin-converting enzyme and converting enzyme inhibitors. In Cellular and Molecular Biology of the Renin-Angiotensin System. M.K. Raizada, M.I. Phillips, and C. Sumners, editors. CRC Press, Boca Raton. 183-220.
14. Howard, T.E., S.-Y. Shai, K.G. Langford, B.M. Martin, and K.E. Bernstein. 1990. Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene. Mol. Cell. Biol. 10: 4294-4302.
15. Langford, K.G., S.-Y. Shai, T.E. Howard, M.J. Kovac, P.A. Overbeek, and K.E. Bernstein. 1991. Transgenic mice demonstrate a testis specific promoter for angiotensin converting enzyme (ACE). J. Biol. Chem. 266:15559-15562.
16. Krege, J.H., S.W.M. John, L.L. Langenbach, J.B. Hodgin, J.R. Hagaman, E.S. Bachman, J.C. Jennette, D.A. O'Brien, and O. Smithies. 1995 Malefemale differences in fertility and blood pressure in ACE-deficient mice. Nature (Lond.). 375:146-148.
17. Esther, C.R., Jr., T.E. Howard, E.M. Marino, J.M. Goddard, M.R. Capecchi, and K.E. Bernstein. 1996. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology and reduced male fertility. Lab. Invest. 74:953-965.
18. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selected genes. Nature (Lond.). 336:348-352.
19. Cushman, D., and H. Cheung. 1971. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20:1637-1648.
20. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
21. Langford, K.G., Y. Zhou, L.D. Russell, J.N. Wilcox, and K.E. Bernstein. 1993. Regulated expression of testis angiotensin-converting enzyme during spermatogenesis in mice. Biol. Reprod. 48:1210-1218.
22. Krege, J.H., J.B. Hodgin, J.R. Hagaman, and O. Smithies. 1995. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension (Dallas). 25:1111-1115.
23. Kim, H.-S., J.H. Krege, K.D. Kluckman, J.R. Hagaman, J.B. Hodgin, C.F. Best, J.C. Jennette, T.M. Coffman, N. Macda, and O. Smithies. 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA. 92:2735-2739.
24. Nimura, F., P.A. Labosky, J. Kakuchi, S. Okubo, H. Yoshida, T. Oikawa, T. Ichiki, A.J. Naftilan, A. Fogo, T. Inagami, et al. 1995. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J. Clin. Invest. 96: 2947-2954.
25. Swales, J.D. 1993. A perspective on extrarenal renin. In The Renin-Angiotensin System. J. Ian, S. Robertson, and M.G. Nicholls, editors. Gower Medical Publishing, London. 48.1-48.14.
26. Friberg, P., B. Sundelin, S.-O. Bohman, A. Bobik, H. Nilsson, A. Wichman, H. Gustafsson, J. Petersen, and M.A. Adams. 1994. Renin-angiotensin system in neonatal rals: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int. 45:485-492.
27. Henderson, I.W., J.A. Oliver, C.M. Milne, and R.J. Balment. 1982. Incidence and characteristics of hydronephrosis in Brattleboro rats. Ann. NY Acad. Sci. 394:21-29.
28. Fauhert, P.H., S.-Y. Chou, and J.G. Porush. 1987. Regulation of papillary plasma flow by angiotensin II. Kidney Int. 32:472-478.
29. Ito, M., M.I. Oliverio, P.J. Mannon, C.F. Best, N. Maeda, O. Smithies, and T.M. Coffman. Regulation of blood pressure by the type 1A angiotensin II receptor gene. 1995. Proc. Natl. Acad. Sci. USA. 92:3521-3525.
30. Hansell, P., M. Sjoquitst, and H.R. Ulfendahl. 1988. Effect of a converting enzyme inhibitor on vasa recta blood flow in rat kidney. Am. J. Physiol. 254: F492-F499.